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Carbohydrates from Pseudomonas aeruginosa biofilms interact
with immune C-type lectins and interfere with their receptor
function
Sonali Singh1,13, Yasir Almuhanna1,2,13, Mohammad Y. Alshahrani1,9, Douglas W. Lowman 3, Peter J. Rice4, Chris Gell1, Zuchao Ma3,
Bridget Graves3, Darryl Jackson1, Kelly Lee1, Rucha Juarez 1, Janice Koranteng 1, Sirina Muntaka1,10, Daniel A. Mitchell5,
Ana C. da Silva 1,6, Farah Hussain1, Gokhan Yilmaz7, Francesca Mastrotto 1,7,11, Yasuhiko Irie1,12, Paul Williams 1,6,8,
David L. Williams3, Miguel Cámara 1,6,8✉ and Luisa Martinez-Pomares 1,8✉
Bacterial biofilms represent a challenge to the healthcare system because of their resilience against antimicrobials and immune
attack. Biofilms consist of bacterial aggregates embedded in an extracellular polymeric substance (EPS) composed of
polysaccharides, nucleic acids and proteins. We hypothesised that carbohydrates could contribute to immune recognition of
Pseudomonas aeruginosa biofilms by engaging C-type lectins. Here we show binding of Dendritic Cell-Specific Intercellular adhesion
molecule-3-Grabbing Non-integrin (DC-SIGN, CD209), mannose receptor (MR, CD206) and Dectin-2 to P. aeruginosa biofilms. We
also demonstrate that DC-SIGN, unlike MR and Dectin-2, recognises planktonic P. aeruginosa cultures and this interaction depends
on the presence of the common polysaccharide antigen. Within biofilms DC-SIGN, Dectin-2 and MR ligands appear as discrete
clusters with dispersed DC-SIGN ligands also found among bacterial aggregates. DC-SIGN, MR and Dectin-2 bind to carbohydrates
purified from P. aeruginosa biofilms, particularly the high molecular weight fraction (HMW; >132,000 Da), with KDs in the nM range.
These HMW carbohydrates contain 74.9–80.9% mannose, display α-mannan segments, interfere with the endocytic activity of cell-
associated DC-SIGN and MR and inhibit Dectin-2-mediated cellular activation. In addition, biofilm carbohydrates reduce the
association of the DC-SIGN ligand Lewisx, but not fucose, to human monocyte-derived dendritic cells (moDCs), and alter moDC
morphology without affecting early cytokine production in response to lipopolysaccharide or P. aeruginosa cultures. This work
identifies the presence of ligands for three important C-type lectins within P. aeruginosa biofilm structures and purified biofilm
carbohydrates and highlights the potential for these receptors to impact immunity to P. aeruginosa infection.
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INTRODUCTION
Pseudomonas aeruginosa is a versatile opportunistic pathogen that
causes acute infection after invasive procedures and burns, and
chronic infections in patients with persistent lung disease and
compromised immunity1. P. aeruginosa infection is especially
troublesome in people with cystic fibrosis where it is a major
determinant of irreversible loss of lung function and mortality2,3.
The use of indwelling catheters and implants during hospital
procedures, as well as use of contact lenses create niches that are
effectively colonised by P. aeruginosa which exploits an armoury
of cell-associated and secreted virulence determinants that
facilitate invasion and establishment of infection4.
The transition from planktonic to sessile growth leading to biofilm
development are central to P. aeruginosa pathogenesis1,4,5. Biofilms
contribute to P. aeruginosa persistence by increasing tolerance to
antimicrobial agents and immune defences1. Within these bacterial
communities, cells are embedded in an extracellular polymeric
substance (EPS) matrix mainly composed of polysaccharides, nucleic
acids and proteins6,7. P. aeruginosa produces three major carbohy-
drates: Psl, Pel and alginate, with Psl and Pel playing major roles in
biofilm formation in a strain-dependent manner6–8. Psl is neutral and
mannose-rich9. Pel is cationic and largely composed of N-acetyl-
galactosamine and N-acetyl-glucosamine10.
Here, we tested the hypothesis that P. aeruginosa biofilms could
directly engage lectin receptors expressed by immune cells. Innate
immune cells11 such as monocytes, macrophages and neutrophils
bear C-type lectin receptors (CLRs) and have been implicated in
immune responses to P. aeruginosa infection12. Dendritic cells,
which are antigen-presenting cells and instrumental in initiating
and modulating adaptive immunity to P. aeruginosa infections13,
also express a host of lectin receptors11.
The mannose receptor (MR, CD206)14, Dendritic Cell-Specific
Intercellular adhesion molecule-3-Grabbing Non-integrin (DC-
SIGN, CD209) and dendritic cell-associated C-type lectin-2
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(Dectin-2, C-type Lectin domain Family 6, Member A) are CLRs
predominantly expressed by populations of myeloid cells14–16. MR
contains two independent carbohydrate-binding domains, the
cysteine-rich domain (MR-CR) and C-type lectin-like domains (MR-
CTLDs) that recognise sulfated and mannosylated sugars, respec-
tively14. DC-SIGN binds to high mannose structures and blood
type Lewis antigens through extracellular CTLD regions clustered
through the formation of tetramers15,17,18. Neither MR nor DC-
SIGN contain bespoke intracellular signalling motifs and rather
than directly inducing cellular activation, modulate signalling
triggered by other receptors such as Toll-like receptors19 and Fc
receptors14,20. Dectin-2 is a transmembrane type II protein
containing a single extracellular CTLD16,21. Dectin-2 lacks signal-
ling motifs but induces an activating signal by engaging the
adaptor molecule Fc receptor common γ chain16,22. Dectin-2
specifically binds glycoconjugates bearing the disaccharide
Manα1–2-Man including fungal α-linked mannans, Malassezia
glycoproteins, and bacterial lipopolysaccharides23. The contribu-
tion of MR, DC-SIGN and Dectin-2 to immunity against infection is
complex. MR and DC-SIGN bind a wide range of pathogens. DC-
SIGN engagement has been associated with immunomodula-
tion24,25 while MR seems to play a redundant role during
infection14 and has been implicated in immunosuppression26 as
well as triggering cellular signalling through FcR common γ
chain27. Dectin-2 mediates immune activation in response to
infection with fungi, Schistosoma mansoni and bacteria28–32.
Here, we demonstrate that DC-SIGN, MR and Dectin-2 recognise
P. aeruginosa biofilms and purified biofilm carbohydrates. In
addition, DC-SIGN binds planktonic P. aeruginosa cultures and this
binding depends on the presence of the common polysaccharide
antigen (CPA) of lipopolysaccharide (LPS)33. We also show that
purified biofilm carbohydrates interfere with the activity of all
three receptors and influence the biology of monocyte-derived
dendritic cells (moDCs). These results suggest a potential role for
C-type lectins in modulating immune responses during P.
aeruginosa biofilm-driven chronic infections.
RESULTS
Analysis of DC-SIGN, MR, and Dectin-2 binding to P.
aeruginosa biofilms
During infection, biofilm formation can alter the range and
distribution of bacterial molecular patterns presented to innate
immune receptors34. Carbohydrates are major components of P.
aeruginosa biofilms8 and strategically posed to engage lectin
receptors, a subset of pattern recognition receptors specialised in
sugar recognition. In particular, the high mannose content of Psl
suggested potential binding to mannose-binding CLRs such as
DC-SIGN, MR and Dectin-2. We queried whether P. aeruginosa
biofilms are directly recognised by DC-SIGN, MR and Dectin-2 by
analysing the interaction of recombinant Fc-chimeric molecules
DC-SIGN-Fc, MR-CTLD4-7-Fc35 and Dectin-2-Fc with biofilms
generated by PAO136 and the exopolysaccharide mutants: ΔwspF
(Psl+ /Pel+)37, ΔwspF Δpel (Psl+ /Pel−) and ΔwspF Δpsl
(Psl−/Pel+)38 and wells containing cultures of the ΔwspF Δpsl
Δpel (Psl−/Pel−) mutant39 which is biofilm-deficient (Table 1). The
ΔwspF background confers constitutive high levels of cyclic-di-
GMP which in turn increases the expression of the Psl and Pel
biosynthetic genes and biofilm formation40. Furthermore, Psl
stimulates a further increase in cyclic-di-GMP levels acting as a
feedback loop in the stimulation of biofilm formation7.
For our study, all biofilms were generated in serum-free
eukaryotic media (X-Vivo-15) to mimic in vivo conditions for
24 h. In this setting, we observed robust biofilm formation by all
ΔwspF mutants expressing Psl and/or Pel while the PAO1 wild-
type biofilms consistently displayed low biomass (Fig. 1a). We
identified strong binding of DC-SIGN to all biofilm cultures,
including PAO1 and the ΔwspF Δpsl (Psl−/Pel+) mutant, but
variable, weak binding to wells with ΔwspF Δpsl Δpel (Psl−/Pel−)
mutant cultures (Fig. 1b). MR-CTLD4-7 and Dectin-2 bound to all
biofilm cultures including PAO1 and the ΔwspF Δpsl (Psl–/Pel+)
mutant but the binding was limited in all instances compared to
DC-SIGN (Fig. 1c). Further analysis demonstrated preferential
inhibition of DC-SIGN binding to PAO1 biofilms by mannose and
fucose compared to galactose (Supplementary Fig. 1).
Due to the high binding of DC-SIGN to ΔwspF Δpsl biofilms and
weak binding to ΔwspF Δpsl Δpel cultures, we investigated
whether DC-SIGN could also interact with planktonic cells. DC-
SIGN recognised P. aeruginosa planktonic cells and binding was
independent of Psl and/or Pel (Fig. 1d). Here bacteria attachment
to wells was independent from biofilm formation. P. aeruginosa
produces two forms of LPS O-antigen; a homopolymer of
D-rhamnose trisaccharide repeats named CPA or A band, and a
heteropolymer that consists of repeating units of three to five
distinct sugars named O-specific antigen (OSA) or B band33.
Deletions in wbpM, rmd, or wbpL in PAO1 causes loss of OSA, CPA,
or both, respectively41. Binding of DC-SIGN to planktonic P.
aeruginosa required expression of rmd or wbpL (Fig. 1e)
suggesting the requirement for CPA LPS. Preliminary imaging
results confirmed DC-SIGN binding to planktonic PAO1 (Supple-
mentary Fig. 2). No Dectin-2 or MR binding to planktonic cells was
observed (Fig. 1d and Supplementary Fig. 2).
To determine whether C-type lectin recognition of P. aeruginosa
biofilms could be extended to the clinical setting we analysed
binding of DC-SIGN, MR and Dectin-2 to biofilms generated by
several wound isolates (Supplementary Figs. 3 and 4). Results
showed a binding pattern similar to that found for the laboratory
strains, with consistently high levels of binding by DC-SIGN
compared to MR and Dectin-2 which bound weakly.
These results demonstrate that P. aeruginosa biofilms produced
by laboratory and clinical isolates display ligands for C-type lectins
with ligands for DC-SIGN being more abundant and/or accessible.
Ligands for DC-SIGN are also present in planktonic cells and depend
on the presence of CPA LPS but not on Psl and/or Pel expression.
Spatial distribution of DC-SIGN, MR, and Dectin-2 ligands
within PAO1 biofilms
To determine the location of DC-SIGN, MR and Dectin-2 ligands within
P. aeruginosa biofilms, we analysed the binding of DC-SIGN, MR and
Dectin-2 Fc proteins to biofilms generated under flow conditions in X-
Vivo-15 medium using confocal microscopy. This approach unveiled
Table 1. Strains used in this study.
Strain Features Reference
PAO1 WT
Physiological levels of c-di GMP
Produces Psl and Pel
36
ΔwspF High cellular levels of c-di GMP
Produces Psl and Pel
37
ΔwspFΔpel High cellular levels of c-di GMP
Produces high levels of Psl
Lacks Pel
38
ΔwspFΔpsl High cellular levels of c-di GMP
Produces high levels of Pel
Lacks Psl
ΔwspFΔpelΔpsl High cellular levels of c-di GMP
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unique ligand distribution for each lectin (Fig. 2). DC-SIGN ligands
were very abundant and dispersed among bacteria aggregates,
reaching substantial density in some areas located in the upper
regions of the biofilm (Fig. 2a and Supplementary Fig. 5, top panels).
MR-CTLD4-7 and Dectin-2 ligands were less abundant (laser intensity
was increased for their detection) and displayed a more granular
distribution (Fig. 2b and Supplementary Fig. 5). Binding was
particularly bright for Dectin-2 compared to MR which contrast with
the ELISA results when both lectins display similar binding. These
differences could be caused by the use on an alternative detection
system or changes in carbohydrate structure when biofilms are
formed under flow conditions. Together these results support the
display of DC-SIGN, MR and Dectin-2 ligands by P. aeruginosa biofilms,
with each receptor exhibiting different binding profiles.
DC-SIGN, MR, and Dectin-2 bind to carbohydrates produced
by P. aeruginosa biofilms
After detecting ligands for DC-SIGN, MR and Dectin-2 in P.
aeruginosa biofilms, it was important to establish whether these
receptors recognised polysaccharides produced during biofilm
formation. Towards this aim, we purified carbohydrates from
biofilm cultures of ΔwspF Δpel (Psl+ /Pel-) (Table 1) to enrich for
mannose-rich polysaccharides as previously described42. Two
independent preparations, 1 and 2, were generated and divided
into high (>45 kDa, HMW) and low molecular weight (<45 kDa,
LMW) fractions by gel filtration chromatography based on
protein standards42. We employed several approaches to
investigate the binding of these carbohydrate preparations to
DC-SIGN, MR and Dectin-2. In the first instance, we tested the
binding of Fc constructs to wells coated with different
concentrations of HMW and LMW (Supplementary Fig. 6). In
all instances, dilution of LMW preparations from 10 to 0.5 µg/ml
had a higher impact on lectin binding than dilution of the HMW
preparations which was indicative of the presence of more
ligands for these CLRs in the HMW fractions (Supplementary
Fig. 6a). Further dilution of HMW-1 and HMW-2 fractions
confirmed dose-dependent binding for DC-SIGN and MR at
0.5 to 0.02 µg/ml (Supplementary Fig. 6b).
Fig. 1 Binding of C-type DC-SIGN, MR and Dectin-2 to P. aeruginosa biofilms and planktonic cells. a PAO1, ΔwspF (Psl+ /Pel+), ΔwspF Δpel
(Psl+ /Pel-), ΔwspF Δpsl (Psl-/Pel+) and ΔwspF Δpsl Δpel (Psl-/Pel-) were grown in 96-well plates for 24 h in X-Vivo-15 and biofilm formation
was analysed using the crystal violet assay. Data analysed using One-way ANOVA and corrected for multiple comparisons using Dunnett’s
multiple comparison test. N= 6-7 in triplicate. ** 0.001; **** <0.0001. b and c. PAO1, ΔwspF, ΔwspF Δpel or ΔwspF Δpsl biofilms were generated
in 96-well plates for 24 h, fixed and incubated with DC-SIGN-Fc (B) or MR-CTLD4-7-Fc or Dectin-2-Fc (C) followed by anti-human Fc secondary
antibody conjugated to alkaline phosphatase. Cultures of ΔwspF Δpsl Δpel were used as controls. Analysis performed using Two-way ANOVA
corrected for multiple comparisons using the Dunnett’s multiple comparisons test. N= 3 in triplicate. In B * 0.0324 (for ΔwspF Δpsl); 0.0413 for
ΔwspF ΔpslΔpel; ** 0.007; *** 0.0007; **** <0.0001. In C **** <0.0001. d Planktonic cultures of P. aeruginosa PAO1 and the different mutants
were collected, fixed and used to coat wells of MaxiSorp plates. Wells were incubated with MR-CTLD4-7-Fc or DC-SIGN-Fc followed by anti-
human Fc secondary antibody conjugated to alkaline phosphatase. DC-SIGN, but not MR, bound planktonic bacteria and binding was
independent of the presence of Psl and/or Pel. Two-way ANOVA corrected for multiple comparisons using the Dunnett’s multiple comparisons
test. N= 4 in triplicate. *, 0.0412 for PAO1 and 0.0148 for ΔwspF; ****, <0.0001.e. DC-SIGN binding to planktonic bacteria was dependent on the
presence of CPA LPS which is absent in the Δrmd and ΔwbpL mutants. N= 3 in triplicate. *, 0.0111; ****, <0.0001. Right panel: Adherence of
planktonic cells to the wells was confirmed by ELISA using an antibody against P. aeruginosa (Anti-PA). N= 3 in triplicate. *, 0.0161. Analysis
performed using Two-way ANOVA corrected for multiple comparisons using the Tukey’s multiple comparisons test. Graphs show mean +/−
SEM. Specificity controls for these assays are shown in Fig. S1. In all cases, reading were taken within 20min development and all strains in
each graph were tested simultaneously.
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Gel permeation chromatography (GPC) confirmed differences in
molecular weight between the HMW and LMW preparations
(15,370 Da for LMW-1 and 182,300 Da and 132,670 Da, for HMW-1
and HMW-2, respectively. LMW-2 size was not investigated)
(Supplementary Fig. 6c). A substantial amount of the material in
all the samples (~33–40% of the total mass) eluted with the
included volume. In our system, this means compounds with low
MW, i.e. 1000 Da. Their nature is unknown, but we propose that
they are carbohydrate breakdown products S6C.
Initial 1H NMR analysis indicated increased level of impurities in
LMW-1 compared to HMW-1 and HMW-2 (data not shown), hence
further work focused on HMW preparations. The hydrolysed
carbohydrate monomer compositions in weight % for HMW-1 is
74.9% mannose, 14.7% glucose, 7.4% galactose, and 3.0%
rhamnose, and for HMW-2 80.9% mannose, 11.0% glucose, 2.3%
galactose, and 5.7% rhamnose. The 1H NMR spectra of HMW-1 and
HMW-2 are very similar (Supplementary Fig. 7a) and indicate that
mannose, the major monomer present, arose from mannan
segments in the polymer43.
To complement previous assays, we tested the ability of HMW-1
to compete for binding of DC-SIGN, MR and Dectin-2 to known
ligands. For this Fc proteins were preincubated with different
concentrations of HMW-1 and then added to wells coated with
fucose-PAA (DC-SIGN and MR) or zymosan (Dectin-2) (Fig. 3). We
observed dose-dependent inhibition in all instances with HMW-1
significantly inhibiting fucose-PAA binding by DC-SIGN from
0.1 µg/ml (Fig. 3a) and by MR from 1 µg/ml (Fig. 3b). HMW-1
inhibited the binding of Dectin-2 to zymosan from 10 µg/ml
(Fig. 3c).
The binding of DC-SIGN, MR and Dectin-2 to biofilm carbohy-
drates was further confirmed using biotinylated tetrameric DC-
SIGN18, full-length human MR and Dectin-2, and HMW-2 and
biolayer interferometry (BLI). Analysis of the binding kinetics
revealed that all three receptors bound HMW-2 with KDs in the nM
range (Fig. 3d). In this experimental setting, the KD for Dectin-2
binding was lower (20 nM KD) compared to DC-SIGN and MR
(103 nM and 114 nM KD, respectively). See Supplementary Fig. 8
for a representative sensorgram of the interaction of Dectin-2 with
HMW-2.
In conclusion, several experimental approaches support the
interaction of DC-SIGN, MR and Dectin-2 with polysaccharides
from P. aeruginosa biofilms. All three receptors bound biofilm
carbohydrates attached to plastic (Lectin ELISAs) and in solution
(competition ELISAs and BLI). Further, binding of MR and Dectin-2
was observed with both human and murine versions of the
receptors (murine receptor-Fc constructs used in the ELISA
binding assays and His-Tagged human receptors used in BLI
assays). For DC-SIGN, Fc and biotinylated tetrameric protein
showed binding. We propose that discrepancies among assays
regarding the strength of these interactions are likely caused by
differences in ligand and receptor clustering among assays, which
will affect binding avidity44.
Biofilm carbohydrates interfere with the endocytic activity of
cell-associated DC-SIGN and MR
To further analyse the interaction between biofilm carbohydrates
and DC-SIGN, MR and Dectin-2, we tested whether these
polysaccharides could impact on receptor activity. First, we
investigated the ability of HMW-1 and HMW-2 to interfere with
the activity of cell-associated DC-SIGN and MR using the stable
transfectants U937-DC-SIGN and CHO-MR45, respectively. We
confirmed the expression of DC-SIGN in U937-DC-SIGN using flow
cytometry (Supplementary Fig. 9a). U937-DC-SIGN cells associate
with the model polymeric ligands Lewisx-PAA-FITC and fucose-
PAA-FITC. Initial results showed inhibition of Lewisx association by
HMW-1 in a dose-dependent manner (50-0.4 µg/ml, Supplemen-
tary Fig. S9B) and that 10 µg/ml provided good inhibition. Based
on these findings we investigated fucose and Lewisx association to
U937-DC-SIGN in the presence and absence of HMW-1 and HMW-
2 (10 µg/ml). Results showed reduced association of both ligands
in the presence of biofilm polysaccharides (Fig. 4a), indicating that
these carbohydrates can compete with both DC-SIGN ligands for
binding.
Fig. 2 Distribution of DC-SIGN, MR and Dectin-2 ligands in P. aeruginosa biofilms. PAO1 biofilms generated underflow conditions for 18 h
as described in materials and methods were incubated with DC-SIGN, MR-CTLD4-7 and Dectin-2 Fc-chimeric proteins followed by anti-human
Fc secondary antibody conjugated to Alexa 647 (magenta) and counterstained with DAPI (DNA, blue) and FM1-43FX (bacteria, green). Z-stacks
were acquired for all samples using confocal microscopy. The figure shows 3D projections for the three receptors based on the initial
detection of bacterial cells during image acquisition. The same settings for image acquisition and processing were maintained for test and
control samples. Scale bar is 4 µm. Brightness and contrast settings in Fiji for DC-SIGN (a) and corresponding secondary antibody control (2nd
Ab) (AF647 channel): minimum and maximum values 48 and 1497, respectively. For MR and Dectin-2 (b) and corresponding 2nd Ab control
(AF647 channel): 330 for both. Settings for FM 1-43 FX and DAPI channels were the same in all instances. All slices for the three receptors are
shown in Supplementary Fig. S5.
S. Singh et al.
4
npj Biofilms and Microbiomes (2021)    87 Published in partnership with Nanyang Technological University
Fucose-PAA-FITC and, weakly, Lewisx-PAA-FITC associated with
CHO-MR cells but not with control CHO cells (Supplementary Fig.
S9c). The association of Lewisx-PAA-FITC to MR-expressing cells
was unexpected as the MR-CTLD4-7 fragment does not bind
Lewisx in ELISA-based assays (Supplementary Fig. 1) and this
polymeric ligand lacks the sulfated moiety required for binding to
MR-CR domain46. Surface plasmon resonance (SPR) analysis using
full-length human MR suggests weak unspecific binding of MR to
Lewisx polymers (Supplementary Fig. 10). HMW-1 and HMW-2
reduced the association of Lewisx-PAA-FITC, but not fucose-PAA-
FITC, to CHO-MR cells. We previously observed good inhibition of
ligand association by a known positive control for MR (mannan) in
these cells indicating that inhibition by a MR ligand is feasible in
this model47. These results suggest that biofilm carbohydrates
interfere with the binding of selected MR ligands, but possibly
only those with very low binding avidity.
These results were reproduced with an HMW-2 preparation
lacking LPS contamination (Supplementary Fig. 11) indicating that
LPS does not contribute to this inhibitory activity. ELISA-based
assays confirmed binding of LPS-free HMW-2 to DC-SIGN and MR
(Supplementary Fig. 12). Together these findings indicate that
biofilm carbohydrates compete with known ligands for cell-
associated DC-SIGN, leading to reduced cellular binding. Findings
for MR indicate weaker competition.
Biofilm carbohydrates act as Dectin-2 antagonists
The high-affinity interaction between the Dectin-2 and HMW-2
suggested the possibility of biofilm polysaccharides triggering
cellular activation through Dectin-2. Hence, we investigated the
ability of Dectin-2 reporter cells (rmDectin-2 HEK cells) to respond
to these carbohydrates. LPS-free HMW-2 was used for these
studies to minimise potential confounding factors caused by LPS
O-antigens. We demonstrated the binding of LPS-free HMW-2 to
Dectin-2 which could be inhibited by the Dectin-2 ligand Mannα1-
2 Mann (Supplementary Fig. 13). In addition, we examined the
binding of LPS-free HMW-2 to rhDectin-2 using BLI. The data
support a KD for the interaction of 0.0186 µM (95% CI=
0.0080–0.0433) which is similar to that previously estimated for
HMW-2 (Fig. 3d).
Dectin-2 reporter cells were exposed to different concentrations
of LPS-free HMW-2 (100, 10, 1, and 0.1 µg/ml) or yeast-derived
zymosan particles, as positive controls. Surprisingly, LPS-free
HMW-2 failed to activate Dectin-2 reporter cells (Fig. 5a) despite
the cells showing a clear response to zymosan particles. An
alternative outcome for the interaction between Dectin-2 and
biofilm polysaccharides is for these carbohydrates to act as
receptor antagonists. To test this possibility Dectin-2 reporter cells
were exposed to different concentrations of LPS-free HMW-2
before being stimulated with zymosan. Under these conditions,
LPS-free HMW-2 (0.3 µg/ml) inhibited the response of Dectin-2
reporter cells to zymosan (Fig. 5b). Analysis of the inhibition of
zymosan response in Dectin-2 reporter cells provides an estimate
for an apparent zymosan dissociation constant of 1.89 µg/mL (95%
CI 1.57–2.22). Thus, these data suggest that LPS-free HMW-2 is
bound by Dectin-2 and does not dissociate from the Dectin-2
receptor, thus preventing zymosan binding and activation. These
data are consistent with the binding data for HMW-2 in which
Fig. 3 Binding of DC-SIGN, MR-CTLD4-7 and Dectin-2 to P. aeruginosa biofilm carbohydrates. a–c. Lectin competition assays demonstrate
dose-dependent inhibition of fucose-PAA (2 µg/ml) binding to DC-SIGN (a) and MR-CTLD4-7 (b), and of zymosan (1 × 106 particles) to Dectin-2
(c), by HMW-1. Fc-chimeric proteins and anti-human Fc-secondary antibody conjugated to alkaline phosphatase were used. Graphs show
mean ± SEM of 4 independent repeats done in duplicate. Analysis was performed using One-way ANOVA corrected for multiple comparisons
using the Dunnett’s multiple comparisons test. ****, <0.0001; ***, 0.0007; **, 0.007, *, 0.0493. d HMW-2 binds rhDC-SIGN, rhMR, and rhDectin-2.
Tetrameric hDC-SIGN, biotinylated and immobilised on a streptavidin sensor and rhMR and rhDectin-2 immobilised on a Ni-sensor were
incubated with different HMW-2 concentrations. The table shows equilibrium dissociation constants for the receptor ligand interaction in μM
(KD); receptor density on the biosensor surface (BMAX) and nonspecific binding (KNON-SPECIFIC). 95% confidence intervals in µM are shown within
brackets.
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there is very little indication of binding dissociation, supporting an
interpretation that HMW-2 acts as a non-displaceable antagonist
for rmDectin-2 attenuating its stimulation by zymosan.
Effect of biofilm carbohydrates on monocyte-derived
dendritic cells
Inhibition of DC-SIGN, Dectin-2 and, partially, MR activities by
biofilm carbohydrates can potentially influence the biology of
immune cells expressing these receptors. Monocyte-derived
dendritic cells (moDCs) offer a good model to study the function
of DC-SIGN and MR in human antigen-presenting cells and we
consistently detected both receptors under our experimental
conditions while Dectin-2 levels were very low in all instances
(Supplementary Fig. 14). To determine if biofilm carbohydrates
could affect the endocytic activity of moDCs, we investigated the
association of selected fluorescein-labelled polymeric ligands with
these cells and how this was affected by HMW-1 and HMW-2.
MoDCs effectively bind fucose-PAA-FITC and Lewisx-PAA-FITC
compared to galactose-PAA-FITC (Fig. 6a). When association
assays were performed in the presence of HMW-1 and HMW-2,
binding of Lewisx-PAA-FITC was significantly reduced while that of
fucose-PAA-FITC or galactose-PAA-FITC remained unaffected (Fig.
6a). These findings were not influenced by the presence of LPS as
Polymyxin B (100 µg/ml) did not alter polymer association in the
presence or absence of biofilm polysaccharides (Supplementary
Fig. 15). Combined with the previous results using the stable cell
lines U937-DC-SIGN and CHO-MR (Fig. 4), these data support the
ability of biofilm carbohydrates to interfere with sugar association
with moDCs. Our findings also unveil the potential for differential
contribution of MR and DC-SIGN to carbohydrate binding by
moDCs; fucose could be preferentially internalised through MR
(not inhibited by HMW biofilm carbohydrates) and LewisX through
DC-SIGN and/or MR (both inhibited by HMW biofilm
carbohydrates).
Next, to establish whether biofilm carbohydrates modulated
other aspects of moDCs biology, we investigated their ability to
induce morphological changes (Fig. 6b) by plating moDCs on
surfaces coated with HMW-2 (prior to LPS removal) or LPS-free
HMW-2. MoDCs cultured with LPS-free HMW-2 for 24 h displayed a
rounder shape, based on their increased Circularity Index, and
reduced Perimeter (Fig. 6b). These morphological changes were
less apparent when using LPS-containing HMW-2 indicating that
LPS could partially reverse this effect. These findings are
consistent with previous results showing reduced DC dendrite
formation after DC-SIGN engagement in moDCs48.
We also explored whether HMW-2 could affect DC-SIGN surface
expression in these assays (Supplementary Fig. 16). Total DC-SIGN
surface expression (Raw Integrated Density) was reduced by
HMW-2 (both crude and LPS-free preparations), but when
adjusting for cell perimeter (Signal per Unit Area) only the cells
exposed to LPS-containing HMW-2 displayed reduced surface DC-
SIGN, which is compatible with a more classical moDC activation
caused by LPS (23).
We next determined the effect of LPS-free HMW-2 (10, 1 and
0.1 µg/ml) on cytokine production by moDCs. LPS-free HMW-2 did
not induce cytokine release by moDCs nor affect cytokine
responses to E. coli LPS (100 and 10 ng/ml) at 4 h (Fig. 6c). We
also investigated whether addition of LPS-free HMW-2 could affect
the cytokine response of moDCs to fixed biofilms and planktonic
cultures using the ΔwspF Δpsl (biofilm-producing) or ΔwspF Δpsl
Δpel (biofilm-deficient) mutant strains, respectively (Supplemen-
tary Fig. 17). Results show similar production of TNF-α, IL-6, Gro-α,
IL-23 and IL-10 in response to ΔwspF Δpsl biofilms and ΔwspF Δpsl
Δpel cultures and increased production of IL-1β in response to
ΔwspF Δpsl biofilms compared to ΔwspF Δpsl Δpel cultures (p <
0.01). As above, LPS-free HMW-2 did not induce cytokine
production by moDCs nor affect cytokine responses to both types
of P. aeruginosa cultures, which would be in agreement with their
Fig. 4 Inhibition of polymeric ligand uptake by DC-SIGN and MR expressing cells by HMW-1 and HMW-2. Cells were treated with HMW-1
or HMW-2 (10 µg/ml) for 1 h, then fluorescein-labelled polymeric ligands were added for a further 1 h. The association of fluorescent polymeric
ligands with cells was measured by flow cytometry. Representative histograms and scatter plots depicting mean ± SEM of median
fluorescence intensity (MFI) are shown for each cell type. a U937-DC-SIGN cells (express DC-SIGN, but not MR) associated with fucose and
Lewisx polymers and this association was reduced by HMW-1 and HMW-2, N= 3. b CHO-MR cells (express MR, but not DC-SIGN) associated
with fucose and Lewisx polymers and only Lewisx association was reduced by HMW-1 and HMW-2, N= 3. One-way ANOVA corrected for
multiple comparisons using the Tukey’s multiple comparisons test. *, ≤0.05. ** ≤0.01. Fuc fucose, Gal galactose.
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ability to bind DC-SIGN (Fig. 1). Combined these findings support a
role for biofilm carbohydrates in modifying moDC biology beyond
modulation of cytokine production in response to bacterial
agonists.
DISCUSSION
Several new findings have emerged from this study. We (i)
demonstrated robust recognition of P. aeruginosa biofilms and
planktonic cells by DC-SIGN (CD209), and weak recognition of
biofilms by MR (CD206) and Dectin-2; (ii) showed binding of DC-
SIGN, MR and Dectin-2 to purified biofilm carbohydrates,
particularly to the high molecular weight fractions; (iii) provided
evidence for biofilm carbohydrates affecting DC-SIGN, MR and
Dectin-2 function and (iv) established the ability of biofilm
carbohydrates to modulate moDC phenotype. The key message
of these studies is that P. aeruginosa produces carbohydrates that
have the potential to influence immunity through the engage-
ment of C-type lectins (Fig. 7). Only MR has been previously
implicated in the recognition of P. aeruginosa biofilms; MR
alongside TLR-2, contributed to the response to Slime-GLP, a
crude ethanol extract of P. aeruginosa biofilm matrix49.
Biofilm-binding assays strongly support a dominant role for DC-
SIGN in recognition of P. aeruginosa biofilms compared to MR and
Dectin-2. This enhanced binding could relate to increased
recognition of the biofilm matrix as suggested by our confocal
study; while ligands for all three lectins appeared to concentrate
into clusters, additional DC-SIGN ligands were more widely
distributed and included material dispersed among bacterial
aggregates. In addition, although not apparent in the confocal
images, there is a possibility of DC-SIGN recognising bacterial cells
within biofilms as these cells tend to retain CPA LPS expression50
which is required for DC-SIGN binding to planktonic cells. Despite
the clear differences between DC-SIGN, MR and Dectin-2 in their
biofilm-binding capabilities, their similar interaction with purified
biofilm polysaccharides in two independent experimental settings
(lectin ELISAs/Fc proteins and BLI/full-length extracellular regions)
suggests that biofilms can generate ligands for DC-SIGN, MR and
Dectin-2 and that steric hindrance could impair access to Dectin-2
and MR ligands within biofilm structures, potentially because of
the presence of carbohydrate-binding proteins such as CdrA51
and/or LecB52,53, which could share binding sites with MR and/or
Dectin-2 ligands. Additionally, since binding to whole biofilms in
the lectin ELISA assays was tested after extensive washing, it is
possible that “firmly associated” (washing-resistant) and “loosely
associated/secreted” (removed by washing) biofilm carbohydrates
are differentially recognised by DC-SIGN, MR and Dectin-2. DC-
SIGN could bind to both “firmly associated” and “loosely
associated/secreted” biofilm carbohydrates, while MR and
Dectin-2 might preferentially bind to the “loosely associated/
secreted” fraction. Culture conditions could also play a role as
exemplified by our confocal analysis when Dectin-2 bound
substantially better than MR to biofilms grown underflow
conditions while both displayed similar binding to biofilms grown
statically in 96-well plates.
Our data do not support a requirement for the psl operon,
responsible for the production of the neutral mannose-rich
carbohydrate Psl8,9, for the biosynthesis of DC-SIGN, MR and
Dectin-2 ligands (Fig. 1). In particular, DC-SIGN binds to biofilms
and planktonic cells regardless of the presence of Psl or Pel. In
relation to these findings, the predicted structure for our HMW
polysaccharide preparations differs from the repeating pentameric
units of D-mannose, L-rhamnose and D-glucose previously
proposed for Psl9. Both HMW exopolysaccharide preparations
contain a small proportion of galactose and lack mannose β
anomers. There is a high proportion of 1-6-linked-α-mannose with
some 1-2 linkages, which is characteristic of mannans (Supple-
mentary Fig. 7a). In Candida albicans the structure of mannan
varies depending on culture conditions54 and it is highly feasible
that differences in growth conditions (which among other things
can affect the expression of CdrA and LecB52, purification
procedures and bacterial strain employed (WT vs ΔwspF Δpel)
could account for these observations. Of note, the structure
described by Byrd et al.9 is for one of two LMW carbohydrate
fractions obtained by Sephadex G50 chromatography. Both LMW
fractions were diminished when Psl was absent but were not
recognised by an anti-Psl antiserum9, that preferentially bound the
HMW carbohydrate fraction in a psl-dependent manner. Intrigu-
ingly, the lack of Psl in this experimental setting did not lead to a
major loss of material in the HMW carbohydrate fraction9 which
suggests that under the experimental conditions used by the
authors there could be a substantial amount of HMW exopoly-
saccharides in P. aeruginosa biofilms produced independently of
the psl operon.
The strain ΔwspF Δpel38 used to generate the carbohydrates in
this study produces high cyclic-di-GMP levels that could impact on
the regulation of carbohydrates. For instance, McCarthy et al.
demonstrated regulation of LPS modifications by cyclic-di-GMP in
Fig. 5 HMW-2 inhibits Dectin-2-mediated cellular activation. a HMW-2 does not induce Dectin-2 activation. Dectin-2 reporter cells (HEK-
blue muDectin-2) and control cells (Null 1 V) (5 × 104 cells per well) were exposed to different stimuli [LPS (1 and 10 µg/ml), Zymosan (1 and
100 µg/ml), laminarin (100 and 1 µg/ml) and LPS-free HMW-2 (100, 10, 1, and 0.1 µg/ml)] for 18 h. Plates were read at OD645 nm. Figure shows
representative image from two independent repeats. b. HMW-2 acts as an antagonist for Dectin-2. Dectin-2 reporter cells (5 × 104 cells per
well) were preincubated with 0.3 µg/ml of LPS-free HMW-2 for 1 h and then exposed to different zymosan doses for 18 h. Plates were read at
OD645 nm. The figure shows representative results from 3 independent repeats.
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P. aeruginosa through binding to WarA, a methyltransferase that
regulates CPA LPS modal distribution55. Exopolysaccharides from
ΔwspF Δpel are recognised by the Psl/mannan-binding lectin LecB
which fails to bind a similar preparation from an isogenic ΔwspF
Δpsl strain52. These results indicate that the synthesis of at least a
proportion of the mannose-rich sugars within the ΔwspF Δpel
material depends on the psl operon. Currently, we do not know
the contribution of the psl operon to the production of the HMW
polysaccharides characterised in this study, nor if it facilitates
generation of DC-SIGN (and MR and Dectin-2) ligands within these
preparations. To address these questions, work is in progress to
purify and analyse carbohydrates from PAO1, ΔwspF Δpsl and
ΔwspF biofilms and study their recognition by C-type lectins. In
the case of MR and Dectin-2, there was some indication of
preferential binding of both lectins to Psl-containing biofilms
(Fig. 1).
In agreement with our carbohydrate analysis, Bates et al. using
the same purification procedure as ours42 identified galactose
alongside mannose, glucose and rhamnose in carbohydrates
generated from biofilms produced by two P. aeruginosa isolates
(700829 and 700888) and there was an abundance of (2–6) linked
(32–28%), 2-linked (20–19%), 3-linked (16%), and terminal
(23–27%) mannose. Hence, there is an exciting possibility for
mannose-rich carbohydrates in P. aeruginosa not being restricted
to Psl, and/or not conforming to a unique structure but displaying
adaptability to environmental changes and/or bacterial genetic
makeup further broadening the range of biofilm architecture and
associated immune responses. The presence of galactose in Psl
preparations has been observed previously56.
It is intriguing that CPA LPS is required for the binding of DC-
SIGN to planktonic cells. The CPA O-antigen consists of repeating
units of [-3)D-rhamnose(α1-3)D-rhamnose(α1-2)D-rhamnose(α1-]
and does not conform to the expected structure of DC-SIGN
Fig. 6 Effect of biofilm carbohydrates on human moDCs. a Human moDCs (MR+ and DC-SIGN+) bind fucose (Fuc), Lewisx and galactose
(Gal) PAA-FITC polymers but only Lewisx association is reduced by HMW-1 and HMW-2. Cells were treated with HMW-1 or HMW-2 (10 µg/ml)
for 1 h, then fluorescein-labelled polymeric ligands were added for a further 1 h. Association of fluorescent polymeric ligands to moDCs was
measured by flow cytometry. Representative histograms are shown as well as a graph depicting mean ± SEM of median fluorescence intensity
(MFI), N= 4. One-way ANOVA corrected for multiple comparisons using the Tukey’s multiple comparisons test. ****, ≤0.0001. Fuc fucose; Gal
galactose. b. Changes in human moDC morphology in the presence of biofilm-associated carbohydrate. HMW-2 (with and without
endogenous LPS, 10 µg/ml, diluted in X-Vivo-15 medium) was used to coat chambers of µ-slide VI 0.4 flow slides overnight at 4 °C. MoDCs
were added (5 × 104 cells per channel) and incubated for 24 h. Samples were then fixed and stained for DC-SIGN (magenta) and nucleus (DAPI,
blue). The figure shows representative images from unpermeabilised samples. Permeabilised samples, including secondary antibody control
are shown in Supplementary Fig. S16. Cells were analysed for changes in shape (Circularity Index), size (Perimeter). Analysis of DC-SIGN
labelling intensity (Raw Integrated Density and Signal per Unit Area) is shown in Supplementary Fig. S16. Data derive from 3 independent
experiments, 20 cells per experiment were analysed. Statistical significance assessed using Kruskal-Wallis test corrected for multiple
comparison using a Dunn’s multiple comparison test. c. LPS-free HMW-2 does not affect cytokine production by moDCs in response LPS.
MoDCs (105 cells per well) were added to 48 well tissue culture plates coated with different doses of LPS-free HMW-2 (10, 1, and 0.1 µg/ml) for
16 h. Cultures were incubated for 2 h and then treated for 4 h with ultrapure E. coli LPS (100 and 10 ng/ml, LPS-100 and LPS-10) and
supernatants collected for cytokine quantification. N= 4. Controls: samples treated with buffer or incubated only with LPS-free HMW-2. Only
samples treated with LPS-100 ng/ml in the presence and absence of LPS-free HMW-2 were analysed for IL-10.
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ligands33. We detected binding of DC-SIGN to LPS purified from P.
aeruginosa serotype 10.2, strain ATCC 27316, using lectin ELISA
(data not shown), which would be consistent with direct
recognition of CPA LPS by DC-SIGN, but at this stage, we cannot
rule out binding of DC-SIGN to the OSA component produced by
this serotype or to contaminating carbohydrates. CPA LPS has
been implicated in biofilm maturation41 and it would be of
interest to establish whether this could be linked to the
generation of DC-SIGN-binding carbohydrates that require CPA
LPS for their secretion and/or synthesis. This hypothesis would be
consistent with the lack of matrix materials in the CPA−/OSA+
(Δrmd) biofilms described by Murphy et al.41. The rmd gene
product is responsible for synthesis of D-rhamnose and does not
contribute to the biosynthesis of any other carbohydrate
structures such as OSA, alginate or rhamnolipids57.
Based on our findings it is plausible to speculate that following
initial infection by planktonic cells, the biofilm lifestyle could
promote chronicity not only by protecting against the immune
attack and antibiotic treatment but also by influencing immune
activation through the engagement of lectin receptors by biofilm
carbohydrates. The consequences of these interactions will
strongly depend on the cellular background, co-engagement of
other receptors and ligand valency58. Our functional studies
support interference with DC-SIGN and Dectin-2 activities by
biofilm carbohydrates that could plausibly affect the biology of
immune cells expressing these lectins. A major effect of biofilm
carbohydrates on MR activity appears less likely. In the case of
moDCs (DC-SIGN+/MR+/Dectin-2low/negative), purified biofilm car-
bohydrates reduced Lewisx uptake and increased circularity. If
these effects are due to DC-SIGN engagement, biofilm carbohy-
drates could interfere with DC-T cell interactions or DC migration
through inhibition of DC-SIGN binding to ICAM-3 or ICAM-2,
respectively59,60. Early work in moDCs described a unique
signalling pathway triggered by DC-SIGN leading to activation of
Rho-GTPases and an immature DC phenotype with reduced
dendrite formation and ability to induce T cell proliferation48.
Future work will centre on the ability of biofilm carbohydrates to
induce Rho-GTPases activation and the consequences of this
interaction on the capacity of moDC to activate T cells. DC-SIGN is
strategically placed to sense P. aeruginosa infection. Previous
observations linked DC-SIGN expression in DCs with biofilm
positivity in chronic rhinosinusitis with nasal polyposis61, and
suggest unique immune responses in the presence of biofilms
that correlate with DC-SIGN expression. In human skin, dermal
macrophages express DC-SIGN62 and could contribute to immune
responses to P. aeruginosa wound infections. DC-SIGN expression
in alveolar macrophages has been described during infection in
tuberculosis patients63.
Dectin-2 belongs to a group of activating C-type lectin
receptors and we initially envisaged its engagement by biofilms
as a counterbalance to immune evasion promoted by DC-SIGN
and MR. Also, while DC-SIGN expression occurs in tissue
macrophages and DCs and could contribute to initial detection
of infection, Dectin-2 could be involved after activation and
recruitment of inflammatory monocytes64,65. Work with Dectin-2
reporter cells indicate that biofilm carbohydrates could hinder
Dectin-2-mediated cellular activation, which could act as an
additional immune evasion mechanism provided by biofilms.
Fig. 7 Involvement of C-type lectin receptors in the recognition of P. aeruginosa. P. aeruginosa biofilms, planktonic cells and high and low
molecular weight biofilm carbohydrates were tested for their interaction with three important C-type lectins: DC-SIGN, MR and Dectin-2. DC-
SIGN seems to play a dominant role in P. aeruginosa recognition based on its ability to bind biofilms, planktonic cells and purified biofilm
carbohydrates, while Dectin-2 and MR preferentially bind purified biofilm carbohydrates. Functionally, purified biofilm carbohydrates interfere
with DC-SIGN, Dectin-2 and, partially, MR activities and influence the phenotype of immune cells (moDCs). These findings implicate C-type
lectins, particularly DC-SIGN, and to some extent Dectin-2, in the detection of P. aeruginosa infection and support a potential role for biofilm
carbohydrates in modulating immunity to P. aeruginosa. DC-SIGN engagement and Dectin-2 blocking in a variety of innate immune cells such
as DCs, macrophages and neutrophils could lead to immune evasion by reducing cellular activation.
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Mouse models offer an excellent setting to investigate cellular
collaborations in response to infection. This is particularly
important in the case of C-type lectins whose expression is cell-
and activation state-dependent. As an example, the collaborative
contribution of C-type lectins expressed by migratory monocytes
during C. albicans infection was recently characterised using
double and triple knock outs for Dectin-1, Dectin-2 and Mincle66.
Since DC-SIGN appears to have a dominant role in P. aeruginosa
recognition, experimental models need to consider lack of DC-
SIGN orthologs in mice15. Researchers have addressed this issue
through the use of DC-SIGN transgenic mice67,68 and we propose
that any analysis of the contribution of C-type lectins to P.
aeruginosa infections, should be performed in the context of DC-
SIGN expression using DC-SIGN transgenic animals. Finally, while
this work has focused on how biofilm carbohydrates could impact
bacterial infection, it is important to consider that polymicrobial
communities are frequently found during chronic infections69.
Since bacteria and fungi co-exist in human diseases, we predict
that biofilm carbohydrates could have a major impact on the
recognition of fungal pathogens by the host. In summary, this
work demonstrates direct interaction between different C-type
lectins and carbohydrates generated by P. aeruginosa as
planktonic cells and biofilms and highlights the possibility that




All strains (Table 1), unless otherwise stated, were grown on Lysogenic
Broth (LB) agar plates from glycerol stocks stored at −80 °C and incubated
overnight at 37 °C. Overnight cultures in X-Vivo-15 medium (Lonza) (5ml,
37 °C, 200/220 rpm) diluted to OD600nm 0.01 were cultured for 3 h at 37 °C,
200/220 rpm. The OD600nm of mid-log phase cultures in X-Vivo-15 was
adjusted to 0.04 OD600nm and 100 μl of cultures were added into each well
of a UV-sterilised 96-well plate [Costar (9017, Corning) or Maxisorp (439454,
Nunc immune-plate)]. Cultures incubated for 24 h at 37 °C, 5% CO2 were
washed three times with 200 μl of HPLC water and stained with 125 μl of
1% (w/v) crystal violet (1 h, room temperature (RT)). After washing three
times in water, the stain was solubilised by adding 200 μl of 70% ethanol for
15min; 125 µl was transferred into a clean 96-well Costar plate to measure
the absorbance at 595 nm using a Multiskan FC (Thermo Scientific).
Analysis of the adhesion of planktonic P. aeruginosa to plastic
Overnight P. aeruginosa cultures were centrifuged at 16,000 × g for 5 min
at 4 °C, washed twice with PBS, and re-suspended in 4% paraformaldehyde
(PFA, 15710-S, Electronic Microscopy Sciences, USA) in PBS for 30min at
4 °C. After fixation, cultures were washed once with PBS, adjusted to 0.5
OD600nm in PBS, and pipetted onto Maxisorp plates (50 µl/well). After
washing three times with PBS wells were blocked by adding 3% (w/v)
bovine serum albumin (BSA) (80400-100, Alpha diagnostics, 50 µl/well) in
PBS and then incubated with rabbit anti-P. aeruginosa polyclonal antibody
(50 µl/well, ab68538, Abcam) diluted 1:1000 in PBS for 90min at RT. After
three washes in PBS, the plate was incubated with goat anti-rabbit IgG
conjugated to alkaline phosphatase diluted 1:2000 (A3687, Sigma, 50 µl/
well) in PBS for 1 h at RT. After three washes with AP buffer (100mM Tris-
HCl, 100 mM NaCl, 1 mM MgCl2, pH 9.5), 50 µl of p-nitrophenyl phosphate
substrate solution (Sigma) were added to each well and incubated for 30-
40min at room temperature in the dark. Absorbance was measured at
405 nm using a Multiskan FC (Thermo Scientific).
Lectin binding assays
Assays for the binding of Fc-chimeric proteins to fixed P. aeruginosa
biofilms, fixed planktonic P. aeruginosa cells and purified carbohydrate
were performed as follows. Biofilms were grown on a Maxisorp (439454,
Nunc immune-plate) plate over 24 h and fixed with 50 µl of 2% PFA in PBS
for 10min at 4 °C. For planktonic P. aeruginosa cells, wells of Maxisorp
plates were coated with fixed bacteria (100 µl/per well) and incubated at
4 °C overnight. Purified biofilm carbohydrate was added to Maxisorp plates
overnight (50 µl/well in 154mM NaCl, 37 °C). In all instances, plates were
washed three times with TSB (10 mM Tris-HCl, pH 7.5, 10 mM CaCl2,
154mM NaCl and 0.05% (v/v) Tween 20). Chimeric proteins MR-CTLD4-7
(CTLD4-7-Fc, prepared in house,35), DC-SIGN (DC-SIGN-Fc, R&D Systems)
and Dectin-2 (Dectin-2-Fc, Enzo) (50 µl/well in TSB) were added and
incubated for 2 h at RT. After three washes with TSB, antihuman Fc-
conjugated to alkaline phosphatase (A9544, Sigma) was added (50 µl/well)
and incubated for 1 h, RT (1:1000 dilution). After washing three times with
TSB, alkaline phosphatase activity was measured as above. Inhibition
assays were carried out as above but using TSB buffer containing 1M NaCl
(TSB-high salt). DC-SIGN was preincubated with different concentrations of
the monosaccharides: mannose (63579, Fluka), fucose (47870, Fluka), or
galactose (4829, Fluka) in TSB-high salt for 30 min at RT. Dectin-2 (and MR-
CTLD4-7) was incubated with different doses of Manα1-2Man (M202,
Dextra) under the same conditions. After pre-incubation, proteins were
added to appropriate wells containing biofilms. Polymers containing L-
fucose, Lewisx or D-galactose (2-5 µg/ml, 50 µl per well, Lectinity) and heat-
killed C. albicans were used as controls. To test the ability of biofilm
carbohydrates to inhibit binding of DC-SIGN and MR to fucose-PAA and
binding of Dectin-2 to zymosan, wells were coated with L-fucose-PAA
(2 µg/ml) or zymosan 1 × 106 particles per well in 50 µl and proteins were
preincubated with different concentration of HMW-1 in TSB for 1 h and
added to wells. Binding was detected as above.
Study of DC-SIGN, MR-CTLD4-7, and Dectin-2 binding to P.
aeruginosa biofilms by confocal microscopy
Biofilms were generated underflow on µ-Slide VI 0.4 (Ibidi), as follows: Mid-
log phase cultures in X-Vivo 15 medium (pre-gassed for 48 h at 37 °C / 5%
CO2) were diluted to OD600nm 0.04 and used to inoculate μ-Slide VI 0.4
channels (30 µl per channel, tissue culture treated) and incubated at 37 °C
for 1 h. Slides were fitted into a syringe pump system, and exposed to flow
(1.6 µl/h, pre-gassed X-Vivo-15) at 37 °C, 5% CO2. After culture, super-
natants were collected, biofilms fixed with 100 µl 4% PFA in PBS for 10min
at 4 °C and washed three times with TSB buffer. Wells were stained with FM
1-43 FX membrane dye (100 µl per channel, 2–10 µg/ml, F35355, Thermo-
fisher) in PBS for 30min on ice. Following three washes with TSB buffer
MR-CTLD4-7, Dectin-2 or DC-SIGN Fc-chimeric proteins (30 µl per channel,
10 µg/ml in TSB buffer) were added and incubated for 2 h at RT. After 3
washes in TSB buffer, goat anti-Human IgG conjugated to Alexa fluor 647
(10 µg/ml, A21445, Invitrogen) and 3%(v/v) Goat serum (D9023, Sigma) in
TSB were added and incubated for 1 h at RT. After 3 washes with TSB, DNA
was labelled with DAPI (2 µg/ml, D9542, Sigma-Aldrich) in PBS for 15min,
RT. Plates were washed with TSB and mounted in Ibidi mounting media
(50001, Ibidi) before storing at 4 °C in the dark. Confocal images were
acquired using Zeiss LSM 880 using a 40x/1.20 water objective, the
collection was not done with filters. Fluorescence emission was collected
between 434 and 515 nm (DAPI), 469-538 nm (FM 1-43FX), 641-688 nm (AF
647). Stack size (49.43 µm, y: 49.43 µm, z: 7.5–12.9 µm). Images were
processed using Fiji70.
Carbohydrate purification
Carbohydrate was extracted42 from cultures of ΔwspF Δpel7 in TSB medium
in 1.5 L flasks (400ml per flask) and incubated statically at 37 °C for five
days. Cultures were treated with 0.02% formaldehyde (v/v) (33220, Sigma-
Aldrich) (1 h, RT, 100 rpm) followed by 275mM NaOH (3 h, RT, 100 rpm,
S318-1, Fisher Scientific) and centrifuged (16,000 × g, 1 h, 4 °C). Super-
natants were collected, filtered and dialysed/concentrated against HPLC
water using VIVAFLOW 200, 12–14 kDa MWCO membrane (Sartorius
Stedim Biotech) to a maximum final volume of 100ml. Concentrates were
treated with tri-chloro-acetic acid (TCA, 20% (w/v), 3000-50, Fisher
scientific) at 4 °C for 30min, centrifuged (16,000 × g, 1 h at 4 °C) and
supernatant incubated with 1.5 volumes of cold 95% (v/v) ethanol (−20 °C,
24 h). The solution was centrifuged at 16,000 × g for 1 h at 4 °C and the
pellet was re-suspended in HPLC water. This step was done twice to
improve purity. The solution was then dialysed against HPLC water using
8–10 kDa MWCO Spectra/Por Float-A-Lyzer G2 Dialysis Device (Z726508,
Sigma-Aldrich), and lyophilized. The lyophilized powder was re-suspended
in PBS (pH 7.4) and fractionated on a HiPrep 26/60, Sephacryl S-200 HR gel
filtration column (17119501, GE Healthcare) calibrated with protein
standards (1511901, Bio-rad). For the gel filtration, the equivalent of 2.4
or 3.6 litres of culture were pooled for each column run. High molecular
weight (>45 kDa) and low molecular weight preparations (<45 kDa) were
pooled, dialysed against HPLC water and lyophilized. Endotoxin was
eliminated by repeated passages (x10) through Pierce high capacity
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endotoxin removal spin columns (88274, Thermofisher) following the
manufacturer’s recommendations.
Carbohydrate analysis
Molecular weight analysis. Molecular weight, polydispersity and polymer
distribution values were derived from gel permeation chromatography (GPC)
with a Viscotek/Malvern GPC system consisting of a GPCMax autoinjector
fitted to a TDA 305 detector (Viscotek/Malvern, Houston, TX). The TDA
contains a refractive index detector, a low angle laser light scattering
detector, a right-angle laser light scattering detector, an intrinsic viscosity
detector and a UV detector (λ= 254 nm). Three Waters Ultrahydrogel
columns, i.e. 1200, 500 and 120, were fitted in series (Waters Corp. Milford,
MA). The columns and detectors were maintained at 40 °C within the TDA
305. The system was calibrated using Malvern pullulan and dextran
standards. The mobile phase was 50mM sodium nitrite. The mobile phase
was filter sterilized (0.45 µm) into a 5 L mobile phase reservoir. Biofilm
carbohydrates samples were dissolved (6mg/ml) in mobile phase (50mM
sodium nitrite, pH 7.3). The samples were incubated for ~60min at 60 °C,
followed by sterile filtration (0.45 μm) and injected into the GPC (50–200 μL).
Sample recovery was routinely >90%. Dn/dc for each sample was calculated
using the OmniSec software (v. 4.6.1.354). The data were analysed using a
single peak assignment in order to obtain an average molecular weight for
the entire polymer distribution. Each sample was analysed in duplicate or
triplicate. Replicate analysis of calibration standards indicated reproducibility
of +/−3%, which is well within the limits of the technique.
Proton nuclear magnetic resonance. Carbohydrate preparations were
structurally characterised by solution-state 1D 1H NMR spectroscopy and
2D COSY and HSQC NMR spectroscopy. 1D NMR data acquisition and
analysis were based on methods from Lowman et al.43,54. Briefly, NMR
spectra were collected on a Bruker Avance III 400 NMR spectrometer
operating at 331°K (58 °C) in 5mm NMR tubes. Each carbohydrate (about
5mg) was dissolved in about 550 µl dH2O (Cambridge Isotope Labora-
tories, 99.8+% deuterated). Chemical shift referencing was accomplished
relative to TMSP at 0.0 ppm. The proton 1D NMR spectra were collected
with 36 scans, 65,536 data points, 20 ppm sweep width centred at 6.2 ppm,
and 1 s pulse delay and processed using exponential apodization with
0.3 Hz line broadening. COSY spectra were collected using 2048 by 128
data points, 16 dummy scans, 64 scans, and 9.0 ppm sweep width centred
at 4.5 ppm and processed with sine apodization in both dimensions and
zero-filled to 1024 data points in f1. HSQC spectra were collected using
1024 by 256 data points, 4 dummy scans, 128 scans, and 6.0 ppm sweep
width in f2 and 185 ppm sweep width in f1 and processed with qsine
apodization in both dimensions and zero-filled to 1024 data points in both
dimensions. Polymer hydrolysis was accomplished by heating the isolate in
4 M TFA at 100 °C for 5 h. Processing was accomplished with Bruker
TopSpin (version 4.0.6) on the MacBook Pro.
Measurement of HMW-2 binding to recombinant human MR,
Dectin-2, and biotinylated DC-SIGN by BLI
Binding experiments were performed on an Octet K2 biolayer interfero-
metry system (ForteBio, San Jose, CA) in 10X Kinetics Buffer at 30 °C and
1000 rpm. Black bottomed 96-well plates were from Grenier Bio-One and
the optical biosensor probes from ForteBio. Recombinant human MR
(CD206) and Dectin-2 with a poly-His-tag were from R&D Systems
(Minneapolis, MN). DC-SIGN was purified from cultures of E. coli BL21/DE3
transformed with the pT5T vector containing the cDNA encoding for the
extracellular region of DC-SIGN. Bacterial pellets from cultures treated with
isopropyl-β-d-thiogalactoside were lysed by sonication. The material in
inclusion bodies was solubilized using 6M guanidine-HCl, 10mM Tris-HCl,
pH 7.0, and 0.01% β-mercaptoethanol. Extracts were dialysed against
loading buffer (1.25M NaCl, 25mM Tris-HCl, pH 7.8, 25mM CaCl2) and DC-
SIGN was purified by affinity chromatography using Man-Sepharose and
anion exchange chromatography on a Mono Q column (Amersham
Biosciences). Biotinylation was performed using N-hydroxysuccinimide
biotin (Sigma-Aldrich, Poole, UK) at a molar ratio of 20:1 reagent: protein
at pH 8.4, 4 °C for 60min18,71. Ni-NTA or SA biosensor was placed in the
instrument, and after an equilibration period of 3min the biosensor was
exposed to either the poly-His-tagged MR or Dectin-2, or the biotinylated
DC-SIGN at a concentration of 0.1 µg/mL for 5min, and then transferred to
10X Kinetics Buffer for 10min to establish the BLI signal from the
immobilized receptor. Following this, a series of eight similar 5min
exposures to 2-fold increasing concentrations (3.125–400mg/ml) of
carbohydrate each followed by 10min dissociation in 10X Kinetics Buffer
were performed. For each exposure, the equilibrium BLI signal was
measured 20 s after the switch to Kinetics Buffer and used in the analysis
of binding. A parallel biosensor with immobilized receptor but not
carbohydrate was placed in 10X Kinetics Buffer and used to control for
receptor dissociation during the experiment. The series of BLI signals for
each concentration was fit to models of nonspecific linear binding,
saturable specific binding, and specific binding plus nonspecific binding
with either local variable or shared global values for each parameter. The
sequential F-statistic with a p < 0.05 was used to select the most
appropriate model for each carbohydrate—receptor interaction. Results
are reported as mean values with 95% confidence intervals for apparent
equilibrium dissociation constant (KD), maximum BLI signal (BMAX), and
nonspecific binding (KNS).
Cell association assay of fluorescent monosaccharide
polymers
U937 cells transfected with human DC-SIGN (U937-DC-SIGN) and control
U937 cells were obtained from the American Type Culture Collection (ATCC)
and grown in suspension in RPMI-1640 medium (R0883, Sigma) containing
10% (v/v) foetal bovine serum (FBS, F9665, Sigma), 2 mM L-glutamine (35050-
038, Gibco), 10mM HEPES buffer (15630-056, Gibco), 1mM sodium pyruvate
(11360-039, Gibco), 4.5 g/L D-glucose (A24940-01, Gibco) and 0.15% (v/v)
sodium bicarbonate (S8761, Sigma). U937 cells were harvested by
centrifugation at 250 × g for 5min, washed in Opti-MEM serum-free media
(Gibco), re-suspended in Opti-MEM, adjusted to 1.25 × 106 cells/ml and
plated in 24 well tissue culture plates (250,000 cells/well, Costar) and
incubated for 30min at 37 °C. Fluorescent monosaccharide polymers: LewisX-
PAA-FITC, fucose-PAA-FITC or galactose-PAA-FITC (Lectinity) were added to
each well (5 μg/ml final concentration) and Opti-MEM to controls. Cultures
were incubated for 1 h at 37 °C and then transferred to fluorescence-
activated cell sorting (FACS tubes) and 1ml of FACS Buffer (0.5% (v/v) FBS,
15mM NaN3 in PBS with Ca2+ and Mg2+ (D8537, Sigma)) was added to each
tube. Cells were washed twice in FACS buffer by centrifugation at 300 × g for
5min and re-suspended in 200 μl of FACS buffer and fixed with 2% (v/v) PFA
in PBS. Cells were analysed using a Beckman Coulter FC500 flow cytometer.
Data were analysed using Kaluza analysis software 1.5a. For cell association
inhibition assays, cells were preincubated with HMW or Opti-MEM for 1 h at
37 °C before addition of fluorescent monosaccharide polymers. A similar
procedure was used for CHO and CHO-MR cells but, being adherent cells, all
washes were done in the wells and cells were harvested using trypsin-EDTA
for analysis by flow cytometry45.
Effect of biofilm carbohydrate on Dectin-2-mediated cellular
activation
Dectin-2 NFκB SEAP reporter cells (HEK-blue 293 muDectin-2, Invivogen) and
control HEK cells (Null 1 V, Invivogen) were added to a 96-well plate at 5 × 104
cells per well. To assess Dectin-2 mediated responses, the cells were exposed
to different stimuli, i.e. LPS (1 and 10 µg/ml), Zymosan (1 and 100 µg/ml),
laminarin (100 and 1 µg/ml) and LPS-free HMW-2 (0.1, 1, 10 and 100 µg/ml)
for 18 h. HEK-blue developing reagent were added to wells and plates were
read at OD645nm. To analyse the effect of biofilm carbohydrates on the
response of Dectin-2 reporter cells to zymosan, 20 µl of LPS-free HMW-2
(0.3 µg/ml), along with negative controls (media, endotoxin free water and
PBS) or a positive control (zymosan, 1 µg/ml) were dispensed into a 96-well
flat-bottomed plate. Cells (5 × 104 cells in 180 µl HEK-Blue Detection Media
per well) were added and incubated for 1 h, 37 °C, 5% CO2. Then serial
dilutions of zymosan in 20 µl) were added to the competition wells
containing the biofilm carbohydrate. The plate was then incubated overnight
and read as above. Estimation of the dissociation constant for zymosan
followed the method of Furchgott (1966) as adapted by Parker and Waud
(1971) for nonlinear analysis72,73. Briefly, concentration-response relationships
were established for zymosan in the absence of LPS-free HMW-2. Then,
individual responses to zymosan in the presence of LPS-free HMW-2 were
compared to establish pairs of zymosan concentrations producing equivalent
responses in the presence (x) and absence (y) of LPS-free HMW-2. These
paired concentrations were fit to a hyperbolic relationship y= (M*x)/K+ x) to
estimate KD (as K-M). The experiment was repeated 3 times.
Generation of human monocyte-derived dendritic cells
Human moDCs were prepared from buffy coats (Blood Transfusion Service,
Sheffield, UK). Use of buffy coats was approved by the Faculty of Medicine
S. Singh et al.
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and Health Sciences Research Ethics Committee. PBMCs were isolated
using Histopaque-1077 (H8889, Sigma) and monocytes were isolated using
human CD14 MicroBeads (130-050-201, Miltenyi Biotec) following the
manufacturer’s protocol. Purified monocytes were cultured in RPMI
complete medium [RPMI-1640 (R0883, Sigma), 15% (v/v) human AB serum
(H4522, Sigma), 2 mM GlutaMAX (G7513, Sigma), 10 mM HEPES (15630056,
Gibco), 50 ng/ml recombinant human granulocyte macrophage
colony–stimulating factor (rhGM-CSF) (130-093-865, Miltenyi Biotec), and
50 ng/ml rh interleukin (IL)-4 (130-093-921, Miltenyi Biotec)] and cultured
at 37 °C, 5%CO2 for 6 days. On Day 3, fresh RPMI complete media
containing growth factors was added to each well.
Analysis of changes in moDC morphology after incubation
with HMW
µ-Slide VI 0.4 tissue culture treated channels (80606, Ibidi) were coated
with HMW (10 µg/ml, in X-Vivo-15) overnight at 4 °C. After washing, and
addition of moDCs (5 × 104 cells per channel in X-Vivo 15 containing GM-
CSF and IL-4) cultures were incubated for 24 h at 37 °C, 5% CO2. Samples
were fixed in 4% PFA (15710-s, EM Grade) in PEM (Cytoskeleton-
preserving buffer PIPES-EGTA-Magnesium, 80 mM PIPES pH 6.8, 5 mM
EGTA, 2 mM MgCl2) for 15 min, RT. Slides were washed in PEM and
blocked with 5% Donkey serum (D9663, Sigma) in PEM (blocking buffer) in
the presence or absence of 0.25% Triton X-100. After 3 washes in PEM,
cells were incubated with a rabbit polyclonal antibody against DC-SIGN
overnight at 4 °C (10 µg/ml, ab5715, Abcam) in blocking buffer and then
with Alexa Fluor 647-AffiniPure Donkey anti-Rabbit IgG (H+ L) (711-605-
152, Jackson ImmunoResearch) 1:500 in blocking buffer. After 3 washes in
PEM, cells were labelled with DAPI (1.5 µg/ml in PBS, D9542, Sigma-
Aldrich), washed in PBS and mounted in Ibidi mounting media (50001,
Ibidi). Confocal images were acquired using Zeiss LSM 710 under 40x/1.3
oil objective, without filters. Fluorescence emission was collected between
410 and 585 nm (DAPI) and 638–755 nm (AF 647). Image size (212.55 µm,
y: 212.55 µm, z: 0.406 µm). Images were analysed using Fiji. Raw Integrated
density and cell perimeter were measured by manually following the
contour of the cell using the segmented line tool (width= 12 nm).
Circularity (the ratio between longer and shortest axes for each cell) was
determined by manually following the contour of the cell using the
freehand line tool. The selected areas were then saved in the ROI manager
for analysis. Single per unit area was calculated by (Raw Integrated
density/area selected using the segmented line tool (width= 12 nm) =
single per unit area).
Analysis of moDCs cytokine production in response to E. coli
LPS in the presence and absence of biofilm carbohydrates
MoDCs were added to 48 well tissue culture plates (105 per well),
coated with different doses of LPS-free HMW-2 (10, 1 and 0.1 µg/ml) for
16 h. Cultures were incubated for 2 h and then treated for 4 h with
ultrapure E. coli LPS (100 and 10 ng/ml, LPS-100, and LPS-10, LPS-EK
Ultrapure from Escherichia coli Invivogen, cat # tlrl-peklps) and
supernatants collected for cytokine quantification. Controls were
moDCs incubated only with LPS-free HMW-2. Cytokines were quanti-
fied using DuoSet ELISA (R&D Systems) and Magnetic luminex assay kits
(R&D Systems).
Statistical analysis
Statistical analysis was performed in GraphPad Prism. Details of specific
tests are provided in figure legends.
Reporting Summary
Further information on research design is available in the Nature Research
Reporting Summary linked to this article.
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